Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease
暂无分享,去创建一个
G. Homanics | M. Bewley | K. Cheng | J. Flanagan | K. Lanoue | K. Skvorak | J. Lazovic | H. S. Paul | Kathleen Griffin | W. J. Zinnanti | K. Griffin
[1] R. Jacobs,et al. Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I. , 2007, The Journal of clinical investigation.
[2] Pengxiang She,et al. Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. , 2007, Cell metabolism.
[3] U. Wendel,et al. Social outcome in adults with maple syrup urine disease (MSUD) , 2007, Journal of Inherited Metabolic Disease.
[4] J. Connor,et al. A diet-induced mouse model for glutaric aciduria type I. , 2006, Brain : a journal of neurology.
[5] Simon C Watkins,et al. Production and characterization of murine models of classic and intermediate maple syrup urine disease , 2006, BMC Medical Genetics.
[6] P. Cowen,et al. Effect of Acute Tyrosine Depletion in Using a Branched Chain Amino-Acid Mixture on Dopamine Neurotransmission in the Rat Brain , 2006, Neuropsychopharmacology.
[7] L. Cynober,et al. Ornithine α-ketoglutarate metabolism in the healthy rat in the postabsorptive state , 2005 .
[8] B. Luhovyy,et al. Brain amino acid requirements and toxicity: the example of leucine. , 2005, The Journal of nutrition.
[9] J. O'Callaghan,et al. Focused microwave irradiation of the brain preserves in vivo protein phosphorylation: comparison with other methods of sacrifice and analysis of multiple phosphoproteins , 2004, Journal of Neuroscience Methods.
[10] S. Schönberger,et al. Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. , 2004, Molecular genetics and metabolism.
[11] M. Wajner,et al. Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease. , 2003, Biochimica et biophysica acta.
[12] P. Kaplan,et al. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation , 2003, Neuroradiology.
[13] E. Puffenberger,et al. Diagnosis and treatment of maple syrup disease: a study of 36 patients. , 2002, Pediatrics.
[14] P. Chikhale,et al. Predominant functional activity of the large, neutral amino acid transporter (LAT1) isoform at the cerebrovasculature , 2001, Neuroscience Letters.
[15] Vincent Schmithorst,et al. Simultaneous correction of ghost and geometric distortion artifacts in EPI using a multiecho reference scan , 2001, IEEE Transactions on Medical Imaging.
[16] C. Vargas,et al. Reduction of large neutral amino acid levels in plasma and brain of hyperleucinemic rats , 2001, Neurochemistry International.
[17] C. Scriver,et al. The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.
[18] C. Vargas,et al. Reduction of large neutral amino acid concentrations in plasma and CSF of patients with maple syrup urine disease during crises , 2000, Journal of Inherited Metabolic Disease.
[19] F. Condé,et al. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies , 2000, Neuroscience.
[20] U. Wendel,et al. Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease. , 1999, Clinical chemistry.
[21] W. Hauber. Involvement of basal ganglia transmitter systems in movement initiation , 1998, Progress in Neurobiology.
[22] M. Hariharan,et al. Systematic approach to the development of plasma amino acid analysis by high-performance liquid chromatography with ultraviolet detection with precolumn derivatization using phenyl isothiocyanate. , 1993, Journal of chromatography.
[23] P. Dodd,et al. Glutamate and γ‐Aminobutyric Acid Neurotransmitter Systems in the Acute Phase of Maple Syrup Urine Disease and Citrullinemia Encephalopathies in Newborn Calves , 1992, Journal of neurochemistry.
[24] L. Becker,et al. Abnormal dendritic development in maple syrup urine disease. , 1992, Pediatric neurology.
[25] J. Repa,et al. Branched-chain and other amino acids in tissues of rats fed leucine-limiting amino acid diets containing norleucine. , 1991, Journal of NutriLife.
[26] P. Harper,et al. Maple syrup urine disease (branched chain ketoaciduria). , 1990, The American journal of pathology.
[27] S. Regunathan,et al. Pyruvate Metabolism in the Brain of Young Rats Intoxicated with Organic and Inorganic Lead , 1984, Journal of neurochemistry.
[28] G. Baños,et al. The Effect of Age upon the Entry of Some Amino Acids into the Brain, and their Incorporation into Cerebral Protein , 1978, Developmental medicine and child neurology.
[29] P. M. Daniel,et al. The mechanism by which glucagon induces the release of amino acids from muscle and its relevance to fasting , 1977, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[30] M. Patel. Inhibition by the branched-chain 2-oxo acids of the 2-oxoglutarate dehydrogenase complex in developing rat and human brain. , 1974, The Biochemical journal.
[31] D. Wilbur,et al. Effect of the branched‐chain α‐keto acids on pyruvate metabolism by homogenates of human brain , 1973 .
[32] C. McKean,et al. THE INFLUENCE OF HIGH PHENYLALANINE AND TYROSINE ON THE CONCENTRATIONS OF ESSENTIAL AMINO ACIDS IN BRAIN , 1968, Journal of neurochemistry.
[33] G. Lynch,et al. Maple Syrup Urine Disease , 1964, Journal of mental deficiency research.
[34] I. Feigin,et al. Neuropathological observations in maple syrup urine disease: branched-chain ketoaciduria. , 1961, Archives of neurology.
[35] Oliver H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[36] J S Cookson,et al. Supervision of Mental Defectives , 1945, British medical journal.
[37] G. A. Dhopeshwarkar,et al. Lipogenesis in the developing brain: Utilization of radioactive leucine, isoleucine, octanoic acid and β-hydroxybutyric acid , 2006, Lipids.
[38] L. Cynober,et al. Ornithine alpha-ketoglutarate metabolism in the healthy rat in the postabsorptive state. , 2005, Metabolism: clinical and experimental.
[39] B. Corkey,et al. Assay of citric acid cycle intermediates and related compounds--update with tissue metabolite levels and intracellular distribution. , 1979, Methods in enzymology.
[40] D. Wilbur,et al. Effect of the branched-chain alpha-keto acids on pyruvate metabolism by homogenates of human brain. , 1973, Journal of Neurochemistry.
[41] J. E. Cremer. Journal of Cerebral Blood Flow and Metabolism Substrate Utilization and Brain Development , 2022 .